Aurinia Pharmaceuticals Inc (AUPH) financial statements (2022 and earlier)

Company profile

Business Address #1203-4464 MARKHAM STREET
VICTORIA BC, BC V8Z 7X8
State of Incorp. AB
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments466 
Cash and cash equivalents232 
Short-term investments234 
Inventory, net of allowances, customer advances and progress billings19 
Inventory19 
Prepaid expense13 
Other current assets1 
Other undisclosed current assets15 
Total current assets:513 
Noncurrent Assets
Operating lease, right-of-use asset5 
Property, plant and equipment4 
Intangible assets, net (including goodwill)8 
Intangible assets, net (excluding goodwill)8 
Other noncurrent assets12 
Total noncurrent assets:30 
TOTAL ASSETS:543 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:35 
Accounts payable4 
Accrued liabilities8 
Employee-related liabilities18 
Other undisclosed accounts payable and accrued liabilities4 
Other liabilities5 
Other undisclosed current liabilities1 
Total current liabilities:41 
Noncurrent Liabilities
Long-term debt and lease obligation8 
Operating lease, liability8 
Liabilities, other than long-term debt16 
Other liabilities16 
Total noncurrent liabilities:24 
Total liabilities:64 
Stockholders' equity
Stockholders' equity attributable to parent, including:479 
Additional paid in capital59 
Accumulated other comprehensive loss(1) 
Accumulated deficit(756) 
Other undisclosed stockholders' equity attributable to parent1,177 
Total stockholders' equity:479 
TOTAL LIABILITIES AND EQUITY:543 

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
Revenues46 
Cost of revenue(1) 
Gross profit:45 
Operating expenses(53) 
Other operating expense, net(1) 
Other undisclosed operating loss(171) 
Operating loss:(181) 
Loss from continuing operations before equity method investments, income taxes:(181) 
Other undisclosed income from continuing operations before income taxes1 
Loss from continuing operations before income taxes:(180) 
Income tax expense(1) 
Net loss available to common stockholders, diluted:(181) 

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
Net loss:(181) 
Other comprehensive loss(0) 
Comprehensive loss, net of tax, attributable to parent:(181) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: